About EDGAR Online | Login
 
The following is an excerpt from a SB-2 SEC Filing, filed by DERMAPLUS INC on 12/29/2004.
Next Section Next Section Previous Section Previous Section
DERMAPLUS INC - SB-2 - 20041229 - CAPITALIZATION

CAPITALIZATION

The following table sets forth the long-term debt and capitalization of the Company as of September 30, 2004 on a historical basis.

The table should be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the Financial Statements and related notes thereto included elsewhere in this Prospectus.

                                                       Actual
                                                       ------
Stockholders' Equity (Deficit):

Common Stock, $.001 par value, 50,000,000 authorized
   4,220,000 shares; issued and outstanding;
   6,790,000 shares (as adjusted - maximum)                   $      4,220

Additional Paid In Capital                                         269,780

Retained Earnings (deficit)                                      (183,957)

Stock Subscription Receivable                                      (1,015)
                                                                   -------

Total stockholders' equity                                          89,028

                                                        $
          Total capitalization                                      89,028
                                                        ==================